R Squared Ltd Makes New $79,000 Investment in Trupanion, Inc. (NASDAQ:TRUP)

R Squared Ltd bought a new position in Trupanion, Inc. (NASDAQ:TRUP) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 1,630 shares of the financial services provider’s stock, valued at approximately $79,000.

Several other large investors also recently added to or reduced their stakes in the business. GAMMA Investing LLC grew its position in Trupanion by 18.5% in the fourth quarter. GAMMA Investing LLC now owns 1,709 shares of the financial services provider’s stock worth $82,000 after acquiring an additional 267 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Trupanion by 7.3% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,861 shares of the financial services provider’s stock worth $414,000 after acquiring an additional 671 shares in the last quarter. JPMorgan Chase & Co. grew its position in Trupanion by 2.7% in the third quarter. JPMorgan Chase & Co. now owns 28,317 shares of the financial services provider’s stock worth $1,189,000 after acquiring an additional 738 shares in the last quarter. Quest Partners LLC bought a new stake in Trupanion in the third quarter worth approximately $37,000. Finally, Check Capital Management Inc. CA grew its position in Trupanion by 2.7% in the third quarter. Check Capital Management Inc. CA now owns 41,460 shares of the financial services provider’s stock worth $1,740,000 after acquiring an additional 1,100 shares in the last quarter.

Trupanion Stock Down 0.9 %

Shares of TRUP opened at $47.44 on Friday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.66 and a current ratio of 1.66. The company has a 50-day simple moving average of $50.24 and a 200-day simple moving average of $46.63. Trupanion, Inc. has a 52 week low of $19.69 and a 52 week high of $57.90. The firm has a market capitalization of $2.01 billion, a P/E ratio of -148.25, a P/E/G ratio of 8.32 and a beta of 1.61.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, beating the consensus estimate of ($0.06) by $0.09. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The firm had revenue of $327.50 million during the quarter, compared to analysts’ expectations of $321.79 million. During the same quarter in the prior year, the firm posted ($0.10) EPS. The company’s revenue for the quarter was up 14.6% on a year-over-year basis. On average, equities research analysts expect that Trupanion, Inc. will post -0.2 earnings per share for the current year.

Insiders Place Their Bets

In other Trupanion news, CFO Fawwad Qureshi sold 622 shares of the firm’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $52.61, for a total value of $32,723.42. Following the completion of the sale, the chief financial officer now owns 9,867 shares in the company, valued at approximately $519,102.87. This trade represents a 5.93 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Emily Dreyer sold 900 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $54.55, for a total value of $49,095.00. Following the completion of the sale, the senior vice president now owns 23,808 shares of the company’s stock, valued at $1,298,726.40. This represents a 3.64 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 28,597 shares of company stock worth $1,522,082. 5.50% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on TRUP. Northland Securities upped their price objective on shares of Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a report on Thursday, October 31st. Piper Sandler upgraded Trupanion from a “neutral” rating to an “overweight” rating and set a $57.00 price objective on the stock in a research note on Thursday, January 23rd. Finally, Stifel Nicolaus increased their target price on Trupanion from $42.00 to $44.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Trupanion currently has an average rating of “Moderate Buy” and an average price target of $45.33.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.